We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $786B
1-Year Est. Return 40.34%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+8.15%
1 Year Est. Return
+40.34%
3 Year Est. Return
+112.81%
5 Year Est. Return
+128.34%
10 Year Est. Return
+415.77%
AUM
$287B
AUM Growth
+$27.6B
Cap. Flow
+$5.51B
Cap. Flow %
1.92%
Top 10 Hldgs %
12.98%
Holding
8,864
New
807
Increased
4,306
Reduced
2,683
Closed
688

Sector Composition

Rank Sector Weight
1 Miscellaneous 49.31%
2 Technology 9.89%
3 Financials 7.42%
4 Healthcare 6.84%
5 Consumer Discretionary 5.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SCSC icon
3976
Scansource
SCSC
$1.17B
$1.28M ﹤0.01%
34,648
+15,876
+85% +$540K
RCKT icon
3977
Rocket Pharmaceuticals
RCKT
$285M
$1.28M ﹤0.01%
56,114
+3,763
+7% +$62.8K
FNDE icon
3978
Schwab Fundamental Emerging Markets Large Company Index ETF
FNDE
$10.3B
$1.28M ﹤0.01%
42,756
+3,571
+9% +$103K
PCK
3979
DELISTED
Pimco California Municipal Income Fund II
PCK
$1.28M ﹤0.01%
127,561
+11,935
+10% +$119K
DMF
3980
DELISTED
BNY Mellon Municipal Income
DMF
$1.27M ﹤0.01%
143,302
+21,851
+18% +$195K
ARQ icon
3981
Arq
ARQ
$88.2M
$1.27M ﹤0.01%
121,177
-39,854
-25% -$476K
SUPN icon
3982
Supernus Pharmaceuticals
SUPN
$2.48B
$1.27M ﹤0.01%
53,575
+10,012
+23% +$243K
TPTX
3983
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$1.27M ﹤0.01%
20,375
-6,739
-25% -$321K
CAH icon
3984
PUT
Cardinal Health
CAH
$51B
$1.26M ﹤0.01%
25,000
– –
HSII
3985
DELISTED
Heidrick & Struggles
HSII
$1.26M ﹤0.01%
38,930
+12,503
+47% +$368K
JHMF
3986
DELISTED
John Hancock Multifactor Financials ETF
JHMF
$1.26M ﹤0.01%
30,759
+1,370
+5% +$54.6K
AMPH icon
3987
Amphastar Pharmaceuticals
AMPH
$1.11B
$1.26M ﹤0.01%
65,464
+1,996
+3% +$38.3K
THOR
3988
DELISTED
Synthorx, Inc. Common Stock
THOR
$1.26M ﹤0.01%
18,056
+10,478
+138% +$299K
FSP
3989
Franklin Street Properties
FSP
$36.4M
$1.26M ﹤0.01%
147,124
+66,578
+83% +$573K
LFC
3990
DELISTED
China Life Insurance Company Ltd.
LFC
$1.26M ﹤0.01%
91,099
+33,855
+59% +$434K
REAL icon
3991
The RealReal
REAL
$1.07B
$1.26M ﹤0.01%
66,673
-17,094
-20% -$327K
IBKR icon
3992
Interactive Brokers
IBKR
$40.4B
$1.26M ﹤0.01%
107,780
+80,040
+289% +$939K
PEGA icon
3993
Pegasystems
PEGA
$5.55B
$1.26M ﹤0.01%
31,542
-6,704
-18% -$254K
JHMU
3994
DELISTED
John Hancock Multifactor Utilities ETF
JHMU
$1.25M ﹤0.01%
36,909
-7,605
-17% -$257K
WNS
3995
DELISTED
WNS Holdings
WNS
$1.25M ﹤0.01%
18,959
-1,819
-9% -$113K
COOP
3996
PUT
DELISTED
Mr. Cooper
COOP
$1.25M ﹤0.01%
+100,000
New +$1.23M
BAR icon
3997
GraniteShares Gold Shares
BAR
$1.4B
$1.25M ﹤0.01%
82,720
+42,511
+106% +$628K
NCV
3998
Virtus Convertible & Income Fund
NCV
$347M
$1.25M ﹤0.01%
54,352
-10,562
-16% -$239K
USRT icon
3999
iShares Core US REIT ETF
USRT
$4.31B
$1.25M ﹤0.01%
22,861
+1,891
+9% +$104K
TRV icon
4000
CALL
Travelers Companies
TRV
$75.7B
$1.25M ﹤0.01%
9,100
– –

Similar funds

UBS Group's Q4 2019 Portfolio in Review

As of Q4 2019, UBS Group held 8,864 positions worth $287B, up 11% from $260B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group's Q4 2019 filing shows 807 new, 4,306 increased, 2,683 reduced and 688 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.3B.

By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, down from 50% a quarter earlier, followed by Technology and Financials.

  • UBS Group's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M.
  • UBS Group added most to UBS Group in Q4 2019, an estimated $1.48B increase.
  • UBS Group's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.3B.
  • UBS Group fully exited Altaba Inc in Q4 2019, selling an estimated $759M.
  • UBS Group's ten largest holdings make up 13% of its $287B portfolio in Q4 2019.
  • UBS Group opened 807 new positions and closed 688 in Q4 2019.
  • UBS Group's portfolio value rose 11% quarter-over-quarter to $287B.

Based on UBS Group's 13F filing for Q4 2019, filed 14 Feb 2020.